“…Moreover, although most studies were focused on well-known inflammatory biomarkers such as CRP, IL-6, IL-10, IL-1α or IL-1β, more than 30 biomarkers of inflammation have been addressed (CRP, IL-1α, IL-1ra, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9 IL-10, IL-12, IL-13, IL-15, IL-17a, IL-23, IL-33, TNF-α, TGF-β, IFN-γ, GM-CSF, MCP-1, MCP-3, MIP1-a, MIP1-b, VEGF, FGF-basic, eotaxin, PDGF-BB, RANTES, ALT, AST, and γ-GTP). More than a half of the studies included in this review ( n = 13, 65.0%) reported significant associations between any of the target EDCs included in this review and different inflammation parameters [ 43 , 56 , 57 , 58 , 59 , 63 , 65 , 66 , 68 , 69 , 70 , 72 , 74 ]. However, one-quarter of the selected studies were classified as medium reporting quality, and a certain degree of risk of bias was observed in more than half of the selected studies.…”